EUVIMEDEUVIMED entdecken
Open Access

Coordinated activity of a central pathway drives associative opioid analgesic tolerance

Yiwen Hou iD, Guichang Zou iD, Xianglian Wang, Hui Guo iD, Xiao Ma iD, Xingyu Cheng iD, Zhiyong Xie, Xin Zuo iD, Jing Xia, Huanhuan Mao iD, Man Yuan, Qi Chen iD und 4 weitere

Science Advances · 10.02.2023 · 9 (6)

DOI: 10.1126/sciadv.abo5627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 10.02.2023. Verfasst von Yiwen Hou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Hefei National Research Center for Physical S…. Hauptthemen laut MEDLINE: Analgesics, Opioid, Opiate Overdose. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opioid analgesic tolerance, a root cause of opioid overdose and misuse, can develop through an associative learning. Despite intensive research, the locus and central pathway subserving the associative opioid analgesic tolerance (AOAT) remains unclear. Using a combination of chemo/optogenetic manipulation with calcium imaging and slice physiology, here we identify neuronal ensembles in a hierarchically organized pathway essential for AOAT. The association of morphine-induced analgesia with an environmental condition drives glutamatergic signaling from ventral hippocampus (vHPC) to dorsomedial prefrontal cortex (dmPFC) cholecystokininergic (CCKergic) neurons. Excitation of CCKergic neurons, which project and release CCK to basolateral amygdala (BLA) glutamatergic neurons, relays AOAT signal through inhibition of BLA μ-opioid receptor function, thereby leading to further loss of morphine analgesic efficacy. This work provides evidence for a circuit across different brain regions distinct for opioid analgesic tolerance. The components of this pathway are potential targets to treat opioid overdose and abuse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidOpiate OverdoseHumansMorphineAnalgesicsNeurons

Substanzen

Analgesics, OpioidMorphineAnalgesics

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Hefei National Research Center for Physical Sciences at the Microscale, University of Science and Technology of Chi…
  • Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei 230088, China.
  • National Institute of Biological Sciences, Beijing 102206, China.
  • Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
  • Anhui Province Key Laboratory of Biomedical Aging Research, Hefei 230026, China.

ORCID-Profile: Yiwen Hou, Guichang Zou, Hui Guo, Xiao Ma, Xingyu Cheng, Xin Zuo, Huanhuan Mao, Qi Chen, Peng Cao, Yupeng Yang, Li Zhang, Wei Xiong

Zitieren

APA

Hou, Y., Zou, G., Wang, X., Guo, H., Ma, X., Cheng, X., Xie, Z., Zuo, X., Xia, J., Mao, H., Yuan, M., Chen, Q., Cao, P., Yang, Y., Zhang, L., & Xiong, W. (2023). Coordinated activity of a central pathway drives associative opioid analgesic tolerance. Science Advances, 9(6). https://doi.org/10.1126/sciadv.abo5627

Vancouver

Hou Y, Zou G, Wang X, Guo H, Ma X, Cheng X, et al. Coordinated activity of a central pathway drives associative opioid analgesic tolerance. Science Advances. 2023;9(6). doi:10.1126/sciadv.abo5627

BibTeX
@article{Hou2023,
  author = {Hou, Yiwen and Zou, Guichang and Wang, Xianglian and Guo, Hui and Ma, Xiao and Cheng, Xingyu and Xie, Zhiyong and Zuo, Xin and Xia, Jing and Mao, Huanhuan and Yuan, Man and Chen, Qi and Cao, Peng and Yang, Yupeng and Zhang, Li and Xiong, Wei},
  title = {Coordinated activity of a central pathway drives associative opioid analgesic tolerance},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {6},
  doi = {10.1126/sciadv.abo5627}
}
Kostenlos starten →